BioCentury
ARTICLE | Company News

SRI International, NIH other news

October 26, 2015 7:00 AM UTC

SRI received a $100 million multi-year contract from NIH’s National Institute for Allergy and Infectious Diseases (NIAID) to develop products to treat radiation exposure. SRI’s SRI Biosciences divisio...